Loading study details...
-
-
-
Participants
Study Information
Loading study information...
Study Description
Loading description...
Sponsor Details
Loading sponsor information...
Interventions & Drugs
Loading interventions...
Timeline
Loading timeline...
-
Complexity Score
Study Complexity Score (1-10)
Measures operational complexity based on:
Measures operational complexity based on:
Phase weightI=1, II=2, III=3
Enrollment size>100=1, >500=2, >1000=3
Geographic reach>2=1, >5=2 countries
Study type bonusInterventional=+1
-
Countries
Geographic Reach
Number of countries where the study is actively recruiting or conducting research. Multi-country studies indicate broader reach and more diverse patient populations.
Number of countries where the study is actively recruiting or conducting research. Multi-country studies indicate broader reach and more diverse patient populations.
-
Study Sites
Clinical Trial Sites
Total number of hospitals, clinics, or research centers participating in this study. More sites typically means faster enrollment and broader patient access.
Total number of hospitals, clinics, or research centers participating in this study. More sites typically means faster enrollment and broader patient access.
-
Duration
Study Duration
Time from study start to primary completion date. Includes enrollment period and follow-up. Longer studies may indicate chronic conditions or long-term safety monitoring.
Time from study start to primary completion date. Includes enrollment period and follow-up. Longer studies may indicate chronic conditions or long-term safety monitoring.
-
Randomized
Randomization
Whether participants are randomly assigned to treatment groups. Randomization reduces selection bias and ensures comparable groups.
Whether participants are randomly assigned to treatment groups. Randomization reduces selection bias and ensures comparable groups.
YesHigher quality evidence
NoPotential selection bias
-
Blinding
Blinding (Masking)
Concealment of treatment assignment from participants and/or researchers to prevent bias.
Concealment of treatment assignment from participants and/or researchers to prevent bias.
Double BlindGold standard
Single BlindPartial protection
Open LabelNo blinding
Study Design & Methodology
Loading methodology...
Eligibility Criteria
Loading criteria...
Study Locations
Geographic distribution of study sites
Loading study locations...
Scientific Profile
Study design analysis, methodology assessment, and scientific rigor scoring
Analyzing scientific methodology...
Advanced Study Analytics
Comprehensive AI-powered insights, market analysis, and predictive metrics
Analyzing competitive landscape...
Similar Studies
Related clinical trials based on condition, intervention, and phase
Finding similar studies...